Hims & Hers (HIMS) Stock Tanked Over 34% After Novo Nordisk Ends Wegovy Deal
Hims & Hers (HIMS) stock pulled back by almost 35% after Novo Nordisk accused the health-tech platform of cheaper knock-offs.
💥 Summer Sale
Save big on our most popular plan
Hims & Hers (HIMS) stock pulled back by almost 35% after Novo Nordisk accused the health-tech platform of cheaper knock-offs.
Broadcom has generated market-beating returns to shareholders in the past decade. Can AVGO stock continue to outperform?
CarMax stock rallied more than 6% on Friday after the used-car retailer crushed consensus estimates in fiscal Q1.
Tesla stock is up nearly 2% today after the EV maker launched its highly anticipated robotaxi service in Austin, Texas.
NCLH is a mid-cap cruise stock that trades at a relatively low multiple in 2025. Here’s why it it could be a good buy right now.
AppLovin is a beaten-down tech stock that is growing at a fast pace. Should you buy the dip in APP stock right now?
Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.